Federal Register / Vol. 72, No. 174 / Monday, September 10, 2007 / Notices 51639 

continue to assess market-based fees, 

whenever practical and feasible. 

(9) 40 U.S.C. § 1314. As discussed in 

greater detail in Section 4.b(1)(D), 

above, this easement authority may be 

used to site antennas and related 

equipment on Federal property under 

GSA’s jurisdiction, custody or control. 

The grant may be made without 

consideration, or with monetary or other 

consideration, at the discretion of the 

head of the agency. 

(10) Section 412 of the GSA General 

Provisions, Consolidated 

Appropriations Act, 2005, Pub. L. 108–

447 (Dec. 8, 2004). This provision 

granted GSA new and additional real 

property disposition authority and the 

authority to retain proceeds from the 

disposal of its real property. In addition 

to giving GSA authority to retain the net 

proceeds from its real property 

disposals, Section 412 granted GSA 

additional new authority to dispose of 

its real and related personal property by 

various means, including by sale, lease, 

exchange, or otherwise. This authority 

is in addition to GSA’s numerous other 

existing statutory authorities applicable 

to the use and disposal of real property 

under its jurisdiction, custody or 

control. For GSA-controlled property 

leased under Section 412 to 

accommodate antennas and related 

equipment, the proceeds of any such 

lease would be deposited into GSA’s 

Federal Buildings Fund. 

(11) Subchapters III and IV of Chapter 

5 of Subtitle I of Title 40 of the United 

States Code. These are GSA’s traditional 

authorities for the disposal of surplus 

property. Surplus real property may be 

leased under these authorities to site 

antennas and related equipment on 

property under the jurisdiction, custody 

or control of GSA. In light of the Section 

412 authority discussed in the 

immediately preceding paragraph, GSA 

may now retain the proceeds from such 

disposals and deposit them into the 

Federal Buildings Fund. 

(12) Federal Management Regulation, 

41 C.F.R. §§ 102–79.70 – 79.100. As 

discussed in Section 4.b(1)(E), above, 

these sections provide regulatory 

guidance on siting antennas on Federal 

property under the jurisdiction, custody 

or control of GSA. 

(13) Office of Management and Budget 

Circular A–25. As discussed in Section 

4.b(1)(G), above, this OMB Circular 

provides guidelines that GSA should 

use to assess fees for services it offers 

and for the sale or use of property or 

resources under its jurisdiction, custody 

or control. 

5. Additional Information 

Further information regarding this 

bulletin may be obtained by contacting 

Mr. Stanley C. Langfeld, Director, 

Regulations Management Division, 

Office of Governmentwide Policy, 

General Services Administration, at 

(202) 501–1737, or 

stanley.langfeld@gsa.gov. 

[FR Doc. E7–17755 Filed 9–7–07; 8:45 am] 

BILLING CODE 6820–EP–S 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Administration for Children and 

Families 

Rulemaking Making Notice of Approval 

On September 5, 2007, the 

Department of Health and Human 

Services published a final rule 

governing error rate reporting under the 

Child Care and Development Fund 

(CCDF). In accordance with the 

Paperwork Reduction Act (PRA), the 

Office of Management and Budget 

(OMB) has approved the forms and 

instructions that will be used to 

implement the final rule on CCDF error 

rate reporting. This notice is published 

under authority of Reporting and 

Recordkeeping Requirements: Final 

Rule (1320.11(k)) published August 29, 

1995. 

Dated: September 4, 2007. 

Robert Sargis, 

Reports Clearance Officer. 

[FR Doc. 07–4410 Filed 9–7–07; 8:45 am] 

BILLING CODE 4184–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, NCI 

Community Networks Program. 

Date: October 4–5, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Courtyard Gaithersburg 

Washingtonian Center, 204 Boardwalk Place, 

Gaithersburg, MD 20878. 

Contact Person: Bratin K. Saha, PhD, 

Scientific Review Administrator, Program 

Coordination and Referral Branch, Division 

of Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

8041, Bethesda, MD 20892, (301) 402–0371, 

sahab@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, CA 077–

033, 034, 039, 040, ‘‘Innovative Technologies 

for Milecular Analysis of Cancer.’’

Date: October 16, 2007. 

Time: 8 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, 5151 Pooks Hill 

Road, Bethesda, MD 20814. 

Contact Person: Jeffrey E. DeClue, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

8059, Bethesda, MD 20892–8329, 301–496–

7904, decluej@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

H—Clinical Groups, Subcommittee H—

Childrens Oncology Group. 

Date: October 22–23, 2007. 

Time: 7 p.m. to 9 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Holiday Inn Georgetown, 2100 

Wisconsin Ave, Washington DC. 

Contact Person: Timothy C. Meeker, MD, 

PhD, Scientific Review Administrator, 

Resources and Training Review Branch, 

Division of Extramural Activities, National 

Cancer Institute, 6116 Executive Boulevard, 

Room 8103, Bethesda, MD 20892, (301) 594–

1279, meekert@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

F—Manpower & Training. 

Date: October 25, 2007. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza—Silver Spring, 8777 

Georgia Avenue, Silver Spring, MD 20910. 

Contact Person: Lynn M. Amende, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8105, 

Bethesda, MD 20892, 301–451–4759, 

amendel@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, 

Application of Emerging Technologies for 

Cancer Research. 

Date: October 31–November 1, 2007. 

Time: 8 a.m. to 5 p.m. 


ebenthall on PRODPC61 with NOTICES
51640 Federal Register / Vol. 72, No. 174 / Monday, September 10, 2007 / Notices 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott Suites, 6711 

Democracy Boulevard, Bethesda, MD 20817. 

Contact Person: Marvin L. Salin, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

7073, Bethesda, MD 20892–8329, 301–496–

0694, msalin@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, NCI Small 

Grant Program. 

Date: November 6–7, 2007. 

Time: 8 a.m. to 1 p.m. 

Agenda: To review and evaluate grant 

applications and/or proposals. 

Place: Renaissance M Street Hotel, 1143 

New Hampshire Avenue, NW., Washington, 

DC 20037. 

Contact Person: Irina V. Gordienko, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Boulevard, Room 

7073, Bethesda, MD 20892–8329, 301–594–

1566, gordienkoiv@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Small 

Grants Program for Cancer Epidemiology. 

Date: November 29–30, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Marriott Bethesda North Hotel & 

Conference Center, 5701 Marinelli Road, 

Bethesda, MD 20852. 

Contact Person: Joyce C. Pegues, PhD, 

Scientific Review Administrator, Special 

Review and Logistics Branch, Division of 

Extramural Activities, NIH National Cancer 

Institute, 6116 Executive Boulevard, Room 

7149, Bethesda, MD 20892–8329, 301–594–

1286, peguesj@mail.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 30, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4381 Filed 9–1–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2) notice 

is hereby given of the following 

meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The purpose of this 

meeting is to evaluate proposals for 

support through the RAID program by 

making available to the research 

community, on a competitive basis, NCI 

new agent development contract 

resources for the preclinical 

development of drugs and biologics. 

The outcome of the evaluation will be 

a decision whether NCI should support 

the request and make available contract 

resources for support through the RAID 

program to the research community and 

NCI new agent development for the 

preclinical development of drugs and 

biologics. The research proposals and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the 

proposed research projects, the 

disclosure of which would constitute a 

clearly unwarranted invasion of 

personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Rapid 

Access to Intervention Development. 

Date: October 9–10, 2007. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To evaluate the Rapid Access to 

Intervention Development Portfolio. 

Place: Bethesda Marriott, Pooks Hill, 5151 

Pooks Hill Road, Bethesda, MD 20814. 

Contact Person: Phyllis G. Bryant, 

Executive Secretary, Program Analyst, 

Developmental Therapeutics Program, 

National Cancer Institute, NIH, 6130 

Executive Boulevard, Rm. 8022, Bethesda, 

MD 20892, (301) 496–8720. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394 Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 

Dated: August 30, 2007. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 07–4382 Filed 9–7–07; 8:45 am] 

BILLING CODE 4140–01–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. Appendix 2), notice 

is hereby given of the following 

meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, CA 07–506: 

‘‘A Data Resource for Analyzing Blood & 

Marrow Transplants (U24)’’. 

Date: October 1, 2007. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6116 

Executive Boulevard, Room 8109, Rockville, 

MD 20852, (Telephone Conference Call). 

Contact Person: Sonya Roberson, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, Division of 

Extramural Activities, National Cancer 

Institute, 6116 Executive Blvd., Room 8109, 

Bethesda, MD 20892, 301–594–1182, 

robersos@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Special Emphasis Panel, Cellular 

Oncology (SEP). 

Date: October 2–3, 2007. 

Time: 9 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Bethesda Marriott, Pooks Hill, 5151 

Pooks Hill Road, Bethesda, MD 20814. 

Contact Person: Shakeel Ahmad, PhD, 

Scientific Review Administrator, Research 

Programs Review Branch, National Cancer 

Institute, Division of Extramural Activities, 

6116 Executive Boulevard, Room 8137, 

Bethesda, MD 20892–8328, (301) 594–0114, 

ahmads@mail.nih.gov. 

Name of Committee: National Cancer 

Institute Initial Review Group, Subcommittee 

I—Career Development. 

Date: October 25, 2007. 

Time: 9 a.m. to 8 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Crowne Plaza Washington Silver 

Spring, 8777 Georgia Avenue, Silver Spring, 

MD 20910. 

Contact Person: Robert Bird, PhD, 

Scientific Review Administrator, Resources 

and Training Review Branch, National 


ebenthall on PRODPC61 with NOTICES